We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Element Solutions
ESI
$9.34B
| $2.21M | ﹤0.01% |
213,567
+12,486
| +6% | +$138K |
|
|
SAIL
1577
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $2.2M | ﹤0.01% |
93,663
+48,133
| +106% | +$1.23M |
|
1578
STAAR Surgical
STAA
$1.14B
| $2.2M | ﹤0.01% |
68,909
+21,370
| +45% | +$833K |
|
|
MSGN
1579
DELISTED
MSG Networks Inc.
MSGN
| $2.2M | ﹤0.01% |
93,321
+25,695
| +38% | +$656K |
|
1580
Winnebago Industries
WGO
$904M
| $2.2M | ﹤0.01% |
90,708
+16,011
| +21% | +$424K |
|
1581
AdvanSix
ASIX
$546M
| $2.19M | ﹤0.01% |
90,199
+14,201
| +19% | +$394K |
|
1582
CarGurus
CARG
$3.34B
| $2.19M | ﹤0.01% |
65,084
+21,745
| +50% | +$872K |
|
1583
Hanmi Financial
HAFC
$961M
| $2.19M | ﹤0.01% |
111,445
+15,518
| +16% | +$331K |
|
1584
Chefs' Warehouse
CHEF
$4.43B
| $2.19M | ﹤0.01% |
68,591
+49,783
| +265% | +$1.73M |
|
|
MYOK
1585
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.19M | ﹤0.01% |
44,885
+14,676
| +49% | +$808K |
|
1586
First Hawaiian
FHB
$3.38B
| $2.19M | ﹤0.01% |
97,344
+9,556
| +11% | +$236K |
|
1587
Evolent Health
EVH
$346M
| $2.19M | ﹤0.01% |
109,796
+41,960
| +62% | +$971K |
|
1588
Copa Holdings
CPA
$6.15B
| $2.18M | ﹤0.01% |
27,717
+719
| +3% | +$56.3K |
|
1589
AngioDynamics
ANGO
$622M
| $2.18M | ﹤0.01% |
108,257
+20,978
| +24% | +$434K |
|
1590
U-Haul Holding Co
UHAL
$14.5B
| $2.18M | ﹤0.01% |
66,390
+1,140
| +2% | +$38.5K |
|
1591
Match Group
MTCH
$8.9B
| $2.18M | ﹤0.01% |
50,888
-6,783
| -12% | -$312K |
|
|
ANAT
1592
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2.18M | ﹤0.01% |
17,104
-355
| -2% | -$44.2K |
|
|
DPLO
1593
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $2.17M | ﹤0.01% |
161,436
+28,901
| +22% | +$487K |
|
1594
Wabash National
WNC
$518M
| $2.17M | ﹤0.01% |
165,869
+25,984
| +19% | +$383K |
|
1595
Elanco Animal Health
ELAN
$13.1B
| $2.17M | ﹤0.01% |
+68,785
| New | +$2.25M |
|
1596
WisdomTree
WT
$3.34B
| $2.17M | ﹤0.01% |
325,597
+53,360
| +20% | +$387K |
|
1597
Renasant Corp
RNST
$4.03B
| $2.16M | ﹤0.01% |
71,490
+20,887
| +41% | +$733K |
|
1598
Upbound Group
UPBD
$1.17B
| $2.15M | ﹤0.01% |
133,041
+22,319
| +20% | +$324K |
|
1599
Antero Resources
AR
$10.6B
| $2.15M | ﹤0.01% |
229,289
-3,866
| -2% | -$57.2K |
|
1600
Acadia Pharmaceuticals
ACAD
$4.96B
| $2.15M | ﹤0.01% |
132,816
+44,513
| +50% | +$864K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.